Achieve Life Sciences, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-74.8M | $-10.2M | $-14.7M | $-14.4M | $-12.7M | $-12.8M | $-12.4M | $-12.5M |
| Depreciation & Amortization | $58.0K | $57.0K | $57.0K | $54.0K | $55.0K | $62.0K | $58.0K | $57.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | $100.0K | $-100.0K | $100.0K | $100.0K | $100.0K | $-100.0K | $100.0K |
| Stock-Based Compensation | $7.0M | $-685.0K | $1.3M | $2.3M | $2.9M | $2.2M | $1.2M | $1.3M |
| Net Cash from Operating Activities | $-10.8M | $-6.9M | $-18.0M | $-11.3M | $-9.1M | $-11.1M | $-9.2M | $-10.4M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-137.8M | $14.3M | $709.0K | $-12.7M | $6.7M | $11.4M | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $168.5M | $21.0K | — | — | — | — | $682.0K | $-8.1M |
| Net Change in Cash | $19.9M | $7.4M | $-11.0M | $-19.9M | $38.9M | $263.0K | $3.2M | $-5.2M |
| Free Cash Flow | — | — | — | — | — | — | — | — |